Literature DB >> 1613852

The treatment of urinary incontinence in children using glutaraldehyde cross-linked collagen.

J Wan1, E J McGuire, D A Bloom, M L Ritchey.   

Abstract

Periurethral injection of polytetrafluoroethylene (PolyTef) paste has been used to correct urinary incontinence for 2 decades. The controversy over distant migration of the paste has led to an interest in alternative materials particularly for the pediatric patient. Glutaraldehyde cross-linked collagen, derived from bovine dermal collagen, is effective in treating urinary incontinence in adults. Eight children with structural urinary incontinence underwent glutaraldehyde cross-linked collagen injection. Fluorourodynamic studies preceded and followed the injections. An average of 10.9 cc glutaraldehyde cross-linked collagen was injected per treatment (range 2.5 to 20). The number of injections per child ranged from 1 to 6 (mean 2.1) and followup averaged 13.75 months (range 6 to 33). Overall, 88% of the patients were cured or improved: 5 (63%) became continent, 2 were improved and 1 had no effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613852     DOI: 10.1016/s0022-5347(17)36533-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  The need for standardization of the valsalva leak-point pressure.

Authors:  S E Swift; J W Utrie
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

2.  Transurethral collagen injection for female stress incontinence.

Authors:  R Elsergany; A N Elgamasy; G M Ghoniem
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

3.  Reproducibility of a new method to determine cough-induced leak-point pressure in women with stress urinary incontinence.

Authors:  H Siltberg; G Larsson; A Victor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

Review 4.  Severe adolescent female stress urinary incontinence (SAFSUI): case report and literature review.

Authors:  Bernard T Haylen; Dianne Avery; Tin Lok Chiu
Journal:  Int Urogynecol J       Date:  2013-09-13       Impact factor: 2.894

Review 5.  The extended use of deflux (dextranomer/hyaluronic acid) in pediatric urology.

Authors:  Gregory E Dean; Leo R Doumanian
Journal:  Curr Urol Rep       Date:  2006-03       Impact factor: 3.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.